Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetLife

79.21
+0.66000.84%
Post-market: 79.210.00000.00%18:02 EDT
Volume:6.58M
Turnover:520.61M
Market Cap:53.17B
PE:12.90
High:79.65
Open:79.14
Low:78.63
Close:78.55
Loading ...

MetLife Inc - to Reinsure $10 Billion U.S. Retail Variable Annuity and Rider Reserves With Talcott

THOMSON REUTERS
·
01 May

MetLife Announces $10 Billion Variable Annuity Risk Transfer Transaction

THOMSON REUTERS
·
01 May

MORNING BID AMERICAS-U.S. economy creaking even before tariffs

Reuters
·
30 Apr

BRIEF-MetLife Inc Says CEO Michel Khalaf's 2024 Total Compensation Was $20.3 Million - SEC Filing

Reuters
·
30 Apr

MetLife Inc Says CEO Michel Khalaf's 2024 Total Compensation Was $20.3 Mln - SEC Filing

THOMSON REUTERS
·
30 Apr

What to Expect From These 4 Insurers This Earnings Season?

Zacks
·
29 Apr

MetLife Inc expected to post earnings of $2.00 a share - Earnings Preview

Reuters
·
29 Apr

MetLife's (NYSE:MET) Upcoming Dividend Will Be Larger Than Last Year's

Simply Wall St.
·
26 Apr

Earnings Preview: American International Group (AIG) Q1 Earnings Expected to Decline

Zacks
·
24 Apr

MetLife Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
24 Apr

MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
23 Apr

MetLife Increases Quarterly Dividend $0.0225 to $0.5675 a Share, Payable June 10 to Holders of Record May 6

MT Newswires Live
·
23 Apr

BRIEF-Metlife Increases Common Stock Dividend By 4.1%

Reuters
·
23 Apr

MetLife Raises Dividend 4.1%

Dow Jones
·
23 Apr

MetLife Increases Common Stock Dividend by 4.1%

THOMSON REUTERS
·
23 Apr

MetLife Inc - Increases Common Stock Dividend by 4.1% to $0.5675 per Share

THOMSON REUTERS
·
23 Apr

MetLife Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
22 Apr

T Rowe Price Equity Income Fund's Strategic Moves: News Corp Reduction Highlights Q1 2025

GuruFocus.com
·
17 Apr

MetLife Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025

Business Wire
·
16 Apr